Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

about

Sensitivity of Lung Resistance and Compliance to Beta-Blocker Induced Bronchoconstriction and Long Acting Beta-Agonist Withdrawal in COPD.Tolerability of Bisoprolol on Domiciliary Spirometry in COPD.

P2860

Q47674664-1410108F-35F8-4AAE-8C8F-FD5BC030751E Q47744550-19500E1E-9375-4AA5-B7AF-2263EEC29B73

P2860

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

Item

http://www.wikidata.org/entity/Q47746323

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@en

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@nl

type

Item

label

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@en

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@nl

prefLabel

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@en

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

@nl

P1476

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD

@en

P2093

A Manoharan

http://www.w3.org/2001/XMLSchema#string

A Morrison

http://www.w3.org/2001/XMLSchema#string

B J Lipworth

http://www.w3.org/2001/XMLSchema#string

P Short

http://www.w3.org/2001/XMLSchema#string

W Anderson

http://www.w3.org/2001/XMLSchema#string

P2860

The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors

Effect of β blockers on mortality after myocardial infarction in adults with COPD: population based cohort study of UK electronic healthcare records

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Beta-blockers reduced the risk of mortality and exacerbation in patients with COPD: a meta-analysis of observational studies.

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contrib

A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

Titration to target dose of bisoprolol vs. carvedilol in elderly patients with heart failure: the CIBIS-ELD trial.

Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease.

P304

785-792

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/QJMED/HCX155

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P50

Sunny Jabbal

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29025008

http://www.w3.org/2001/XMLSchema#string

P921

chronic obstructive pulmonary disease

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

about

P2860

P2860

Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921